The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice
Sign Up to like & getrecommendations! Published in 2022 at "Eye"
DOI: 10.1038/s41433-022-02008-3
Abstract: Untreated neovascular age-related macular degeneration (nAMD) can lead to severe and permanent visual impairment. The chronic nature of the disease can have a significant impact on patients’ quality of life and an economic and time… read more here.
Keywords: neovascular amd; management patients; patients neovascular; amd brolucizumab ... See more keywords